Foster Wheeler on Wednesday announced its acquisition
of Yonkers Industries, a 30-year-old,
US-based company that specializes in the management of
construction and commissioning of pharmaceutical and biotech facilities.
Yonkers also has capabilities to manage the full EPCm
(engineering, procurement and construction management) of such facilities, according to Foster
With offices in California, North Carolina and Puerto Rico,
Yonkers Industries has approximately 200 professionals.
Through its participation in a project-services partnership called
Modular Partners, Yonkers also has the ability to provide
modular project delivery services on a
The acquisition of Yonkers Industries gives our
pharmaceutical business a construction management capability
in North America, said Kent Masters, CEO of Foster
Wheeler. Yonkers has a global reputation for excellence
in contract execution, and the addition of this construction
management capability immediately strengthens our value
proposition to pharmaceutical and biotech clients.
Foster Wheeler Biokinetics, our US-based
pharmaceutical unit, will experience the most immediate benefit
from this acquisition as the client portfolios and
geographic coverage of the two companies fit together quite
effectively," Masters continued.
"We believe that the project and construction management skills of
Yonkers are a perfect complement to the biotech engineering
expertise of Biokinetics.